Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colon, Transverse | 2 | 2018 | 23 | 0.820 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 327 | 0.660 |
Why?
|
| Astrocytoma | 9 | 2011 | 790 | 0.580 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2009 | 729 | 0.540 |
Why?
|
| Stomach Neoplasms | 2 | 2019 | 1332 | 0.420 |
Why?
|
| Sepharose | 2 | 2009 | 108 | 0.400 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 1637 | 0.400 |
Why?
|
| Brain Neoplasms | 17 | 2011 | 8856 | 0.310 |
Why?
|
| Supratentorial Neoplasms | 3 | 2018 | 160 | 0.280 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2007 | 1083 | 0.250 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 5264 | 0.250 |
Why?
|
| Mutism | 2 | 2012 | 24 | 0.210 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 6363 | 0.180 |
Why?
|
| Neurilemmoma | 1 | 2005 | 547 | 0.180 |
Why?
|
| Glioblastoma | 7 | 2018 | 3480 | 0.180 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 902 | 0.170 |
Why?
|
| Gastrectomy | 2 | 2019 | 663 | 0.150 |
Why?
|
| Oligodendroglioma | 2 | 2011 | 279 | 0.150 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2005 | 895 | 0.150 |
Why?
|
| Cecum | 1 | 2017 | 237 | 0.150 |
Why?
|
| Intussusception | 1 | 2017 | 114 | 0.140 |
Why?
|
| Carcinoma, Small Cell | 1 | 2019 | 420 | 0.140 |
Why?
|
| Carcinoid Tumor | 1 | 2017 | 235 | 0.140 |
Why?
|
| Lymphoma | 2 | 2018 | 1875 | 0.140 |
Why?
|
| Appendiceal Neoplasms | 1 | 2017 | 146 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2013 | 2739 | 0.130 |
Why?
|
| Cerebellum | 2 | 2012 | 1487 | 0.130 |
Why?
|
| Ileum | 1 | 2017 | 565 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 16674 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 2 | 2012 | 587 | 0.120 |
Why?
|
| Staurosporine | 2 | 2007 | 251 | 0.120 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2924 | 0.120 |
Why?
|
| Lactic Acid | 2 | 2011 | 1131 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2018 | 1262 | 0.110 |
Why?
|
| Cerebrum | 1 | 2012 | 137 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2009 | 13691 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3617 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3583 | 0.090 |
Why?
|
| Pons | 1 | 2011 | 244 | 0.090 |
Why?
|
| Rhabdoid Tumor | 1 | 2012 | 212 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4152 | 0.090 |
Why?
|
| Teratoma | 1 | 2012 | 393 | 0.080 |
Why?
|
| Brain Stem Neoplasms | 1 | 2011 | 204 | 0.080 |
Why?
|
| Agar | 1 | 2008 | 56 | 0.080 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2010 | 341 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1434 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1205 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 355 | 0.080 |
Why?
|
| Cytoplasm | 3 | 2009 | 1536 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6895 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 323 | 0.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2008 | 53 | 0.080 |
Why?
|
| Iodine | 1 | 2010 | 286 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 461 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11524 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2007 | 2963 | 0.070 |
Why?
|
| Gadolinium DTPA | 1 | 2010 | 836 | 0.070 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2006 | 45 | 0.070 |
Why?
|
| Chromatids | 1 | 2006 | 63 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2006 | 215 | 0.070 |
Why?
|
| Meningioma | 2 | 2013 | 1209 | 0.070 |
Why?
|
| Cell Nucleus | 4 | 2009 | 2969 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2542 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2006 | 705 | 0.070 |
Why?
|
| Retinoblastoma Protein | 2 | 2007 | 705 | 0.070 |
Why?
|
| Neurosurgical Procedures | 3 | 2012 | 2002 | 0.070 |
Why?
|
| Cell Cycle Proteins | 3 | 2007 | 3463 | 0.060 |
Why?
|
| Aged | 19 | 2018 | 163178 | 0.060 |
Why?
|
| Carboplatin | 1 | 2008 | 801 | 0.060 |
Why?
|
| Humans | 36 | 2022 | 743811 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2005 | 259 | 0.060 |
Why?
|
| Vimentin | 1 | 2005 | 262 | 0.060 |
Why?
|
| Glioma | 3 | 2011 | 3401 | 0.060 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2007 | 476 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 1285 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1444 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2008 | 1654 | 0.060 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 1241 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2369 | 0.060 |
Why?
|
| Brain Stem | 1 | 2008 | 844 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 3758 | 0.060 |
Why?
|
| Contrast Media | 3 | 2013 | 5301 | 0.050 |
Why?
|
| Ganglioglioma | 1 | 2002 | 42 | 0.050 |
Why?
|
| Male | 25 | 2019 | 349776 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2006 | 3706 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2012 | 35409 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2646 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4251 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1677 | 0.050 |
Why?
|
| Cell Death | 1 | 2007 | 1705 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2440 | 0.050 |
Why?
|
| Middle Aged | 20 | 2019 | 213241 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2010 | 1102 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 3320 | 0.050 |
Why?
|
| Prognosis | 8 | 2011 | 29052 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2509 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2017 | 1367 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2914 | 0.040 |
Why?
|
| Female | 26 | 2018 | 380020 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4749 | 0.040 |
Why?
|
| Oxonic Acid | 1 | 2019 | 41 | 0.040 |
Why?
|
| Tegafur | 1 | 2019 | 49 | 0.040 |
Why?
|
| Adult | 18 | 2018 | 213889 | 0.040 |
Why?
|
| Cell Survival | 1 | 2009 | 5881 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2006 | 1640 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 1416 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 3503 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10940 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14714 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2002 | 627 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2017 | 8637 | 0.040 |
Why?
|
| Receptor, erbB-2 | 2 | 2006 | 2418 | 0.040 |
Why?
|
| Occult Blood | 1 | 2017 | 176 | 0.040 |
Why?
|
| Medulloblastoma | 1 | 2002 | 683 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 2944 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 12954 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3794 | 0.030 |
Why?
|
| Mice | 1 | 2022 | 81154 | 0.030 |
Why?
|
| Adolescent | 9 | 2011 | 85729 | 0.030 |
Why?
|
| Alleles | 1 | 2006 | 6934 | 0.030 |
Why?
|
| Treatment Outcome | 8 | 2017 | 63042 | 0.030 |
Why?
|
| Retrospective Studies | 8 | 2018 | 77410 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2017 | 550 | 0.030 |
Why?
|
| Lipids | 1 | 2005 | 3307 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 365 | 0.030 |
Why?
|
| Survival Rate | 4 | 2011 | 12786 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 1958 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9239 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 11360 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13112 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2008 | 2274 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 57744 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6773 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 229 | 0.030 |
Why?
|
| Cisplatin | 1 | 2019 | 1662 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10477 | 0.030 |
Why?
|
| Colectomy | 1 | 2017 | 680 | 0.030 |
Why?
|
| Algorithms | 2 | 2010 | 13869 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 2899 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 1352 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 168660 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2017 | 1098 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2013 | 550 | 0.020 |
Why?
|
| Spin Labels | 1 | 2012 | 332 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 588 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
| Child | 8 | 2011 | 77637 | 0.020 |
Why?
|
| Child, Preschool | 5 | 2012 | 40964 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12066 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 980 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 19894 | 0.020 |
Why?
|
| Nicardipine | 1 | 2008 | 60 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2007 | 5179 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 644 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13028 | 0.020 |
Why?
|
| Young Adult | 5 | 2011 | 56392 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 5892 | 0.020 |
Why?
|
| Apoptosis | 1 | 2003 | 9718 | 0.020 |
Why?
|
| Nitrosourea Compounds | 1 | 2006 | 32 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2006 | 6311 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 862 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 644 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 157 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3503 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 39001 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 545 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2017 | 2148 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1157 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13404 | 0.020 |
Why?
|
| Kinetochores | 1 | 2006 | 194 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2883 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2007 | 10251 | 0.010 |
Why?
|
| Mosaicism | 1 | 2006 | 441 | 0.010 |
Why?
|
| G2 Phase | 1 | 2003 | 139 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2003 | 219 | 0.010 |
Why?
|
| Infant | 4 | 2006 | 35122 | 0.010 |
Why?
|
| G1 Phase | 1 | 2003 | 415 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2005 | 982 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 40038 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2037 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2503 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2839 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29777 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 2034 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15526 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 528 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8337 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2010 | 2251 | 0.010 |
Why?
|
| Cyclins | 1 | 2003 | 603 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1770 | 0.010 |
Why?
|
| Protons | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2010 | 2915 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3249 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2764 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20121 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 1100 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 2047 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2006 | 8430 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 7010 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3480 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2007 | 2922 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2002 | 1851 | 0.010 |
Why?
|
| Radiosurgery | 1 | 2005 | 1331 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8939 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 12354 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13809 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3421 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18107 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 24250 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19232 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18355 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18027 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 8480 | 0.000 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_